scholarly article | Q13442814 |
P50 | author | Harold L. Moses | Q47005604 |
P2093 | author name string | A E Gorska | |
R Serra | |||
H Joseph | |||
P Sohn | |||
P2860 | cites work | Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 |
Mechanism of activation of the TGF-beta receptor | Q28245861 | ||
Determination of type I receptor specificity by the type II receptors for TGF-beta or activin | Q28256128 | ||
HGF/SF: a potent cytokine for mammary growth, morphogenesis and development | Q28289006 | ||
Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-beta 1 and glucocorticoids | Q28317703 | ||
Regulated expression and growth inhibitory effects of transforming growth factor-beta isoforms in mouse mammary gland development | Q28587489 | ||
Regulation of mammary morphogenesis: Evidence for extracellular matrix-mediated inhibition of ductal budding by transforming growth factor-β1 | Q33232601 | ||
Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity | Q33845898 | ||
Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas | Q33886619 | ||
Targeting expression of a transforming growth factor beta 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. | Q34050002 | ||
Laminin mediates tissue-specific gene expression in mammary epithelia | Q34058782 | ||
Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. | Q34167993 | ||
Mammary tumor suppression by transforming growth factor beta 1 transgene expression | Q34316245 | ||
Requirement for BMP signaling in interdigital apoptosis and scale formation. | Q34377113 | ||
Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development | Q34452052 | ||
Insulin-like growth factor-I and insulin-like growth factor binding protein-3 inhibit involution of the mammary gland following lactation: studies in transgenic mice | Q71559313 | ||
Immunolocalization and expression of insulin-like growth factor I (IGF-I) in the mammary gland during rat gestation and lactation | Q71626832 | ||
Inhibins and activins regulate mammary epithelial cell differentiation through mesenchymal-epithelial interactions | Q73517182 | ||
Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice | Q74446505 | ||
Epithelium-dependent extracellular matrix synthesis in transforming growth factor-beta 1-growth-inhibited mouse mammary gland | Q34630674 | ||
OVEC, a versatile system to study transcription in mammalian cells and cell-free extracts | Q34703535 | ||
Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor | Q35961109 | ||
Expression of a dominant-negative type II transforming growth factor beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF-beta-mediated growth inhibition | Q36042415 | ||
TGF-beta 1-induced inhibition of mouse mammary ductal growth: developmental specificity and characterization. | Q36145821 | ||
TGF beta suppresses casein synthesis in mouse mammary explants and may play a role in controlling milk levels during pregnancy | Q36232199 | ||
Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression | Q36233928 | ||
Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland | Q36236069 | ||
Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis | Q36273884 | ||
New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues | Q36366470 | ||
Reversible inhibition of mammary gland growth by transforming growth factor-beta | Q36459241 | ||
Construction and preliminary characterization of the rat casein and alpha-lactalbumin cDNA clones. | Q36641716 | ||
Characterization of the 5′-Flanking Region of the Hepatocyte Growth Factor Gene | Q36696782 | ||
A mouse TGF-beta type I receptor that requires type II receptor for ligand binding. | Q36743217 | ||
Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1. | Q36757191 | ||
Structural and functional characterization of the mouse hepatocyte growth factor gene promoter. | Q36762650 | ||
Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region | Q36826768 | ||
Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts | Q36914099 | ||
Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model | Q37354895 | ||
Effects of truncated activin and FGF receptors and of follistatin on the inducing activities of BVg1 and activin: does activin play a role in mesoderm induction? | Q37634988 | ||
TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights | Q37956083 | ||
Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-beta receptors. | Q38291682 | ||
TGF-beta 1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence | Q38341183 | ||
Regulation of differentiation by TGF-beta | Q41239396 | ||
Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts | Q41362675 | ||
Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells | Q41375138 | ||
Inhibition of myogenic differentiation in myoblasts expressing a truncated type II TGF-beta receptor. | Q41470938 | ||
Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities. | Q41552765 | ||
Development of mammary preneoplasias in vivo from mouse mammary epithelial cell lines in vitro | Q41632754 | ||
Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor | Q41656206 | ||
Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines | Q41719856 | ||
Apoptotic cell death and tissue remodelling during mouse mammary gland involution | Q42462200 | ||
Transforming growth factor-beta 1 inhibits casein secretion from differentiating mammary-gland explants but not from lactating mammary cells | Q42830496 | ||
Characterization of the promoter region of the rat hepatocyte-growth-factor/scatter-factor gene. | Q48126126 | ||
The presence of hepatocyte growth factor in the developing rat | Q48429605 | ||
Activin/inhibin beta B subunit gene disruption leads to defects in eyelid development and female reproduction. | Q52218306 | ||
Transforming growth factor production by chemically transformed cells | Q52826927 | ||
In situ hybridization analysis of TGF beta 3 RNA expression during mouse development: comparative studies with TGF beta 1 and beta 2 | Q67709946 | ||
A dominant-negative receptor for type beta transforming growth factors created by deletion of the kinase domain | Q70458477 | ||
P4510 | describes a project that uses | ImageQuant | Q112270642 |
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | overexpression | Q61643320 |
P304 | page(s) | 1221-1234 | |
P577 | publication date | 1999-04-01 | |
P1433 | published in | Molecular Biology of the Cell | Q2338259 |
P1476 | title | Overexpression of a kinase-deficient transforming growth factor-beta type II receptor in mouse mammary stroma results in increased epithelial branching | |
P478 | volume | 10 |
Q50769739 | A 7.1 kbp beta-myosin heavy chain promoter, efficient for green fluorescent protein expression, probably induces lethality when overexpressing a mutated transforming growth factor-beta type II receptor in transgenic mice. |
Q36814529 | A delicate balance: TGF-beta and the tumor microenvironment |
Q37302280 | A functional connection between pRB and transforming growth factor beta in growth inhibition and mammary gland development |
Q37414190 | Bcl-2 expression is altered with ovarian tumor progression: an immunohistochemical evaluation |
Q39203508 | Building branched tissue structures: from single cell guidance to coordinated construction. |
Q33918879 | Cathepsin B is the driving force of esophageal cell invasion in a fibroblast-dependent manner |
Q37106657 | Choreographing metastasis to the tune of LTBP. |
Q36660547 | Comparative mechanisms of branching morphogenesis in diverse systems |
Q35522542 | Crosstalk between TGF-beta and MAPK signaling during corneal wound healing |
Q38219828 | Cytokine networks that mediate epithelial cell-macrophage crosstalk in the mammary gland: implications for development and cancer. |
Q29616379 | Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer |
Q52566550 | Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling. |
Q36233911 | ECM degrading proteases and tissue remodelling in the mammary gland |
Q42473280 | Expansion of stem cells counteracts age-related mammary regression in compound Timp1/Timp3 null mice. |
Q42440126 | Fibroblast-specific Expression of a Kinase-deficient Type II Transforming Growth Factor β (TGFβ) Receptor Leads to Paradoxical Activation of TGFβ Signaling Pathways with Fibrosis in Transgenic Mice |
Q36971355 | Genetic mosaic analysis reveals FGF receptor 2 function in terminal end buds during mammary gland branching morphogenesis |
Q33845036 | Hormonal and local control of mammary branching morphogenesis |
Q34565505 | Hormone/growth factor interactions mediating epithelial/stromal communication in mammary gland development and carcinogenesis |
Q37914678 | Integrated morphodynamic signalling of the mammary gland |
Q35747946 | Latent transforming growth factor-beta activation in mammary gland: regulation by ovarian hormones affects ductal and alveolar proliferation |
Q42586464 | Links between transforming growth factor-beta and canonical Wnt signaling yield new insights into breast cancer susceptibility, suppression and tumor heterogeneity |
Q37208778 | Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype |
Q34781947 | Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks |
Q36026081 | Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression |
Q33587338 | Loss of the heparan sulfate sulfotransferase, Ndst1, in mammary epithelial cells selectively blocks lobuloalveolar development in mice |
Q33272861 | Low concentrations of transforming growth factor-beta-1 induce tubulogenesis in cultured mammary epithelial cells |
Q37690702 | Ltbp1L is focally induced in embryonic mammary mesenchyme, demarcates the ductal luminal lineage and is upregulated during involution |
Q42159260 | Mammary branch initiation and extension are inhibited by separate pathways downstream of TGFβ in culture |
Q33735595 | Mammary development and breast cancer: the role of stem cells |
Q34136247 | Mammary ductal and alveolar development: lesson learned from genetically manipulated mice |
Q24629797 | Mammary gland development |
Q37854682 | Molecular regulators of pubertal mammary gland development |
Q24797078 | New highlights on stroma-epithelial interactions in breast cancer |
Q44948266 | Non-redundant tumour supressor functions of transforming growth factor beta in breast cancer |
Q37071457 | Oncogenic transformation of mammary epithelial cells by transforming growth factor beta independent of mammary stem cell regulation |
Q30434164 | Organogenesis of the exocrine gland |
Q31911446 | Postnatal mammary gland morphogenesis |
Q28278555 | Prostate cancer and the met hepatocyte growth factor receptor |
Q21092901 | Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes |
Q33844240 | Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. |
Q35056355 | Stage-dependent regulation of mammary ductal branching by heparan sulfate and HGF-cMet signaling. |
Q33663923 | Stroma in breast development and disease. |
Q33681686 | TGF- Biology in Mammary Development and Breast Cancer |
Q39950912 | TGF-beta promotes Th17 cell development through inhibition of SOCS3. |
Q34316170 | TGF-beta signaling in mammary gland development and tumorigenesis. |
Q45263240 | TGF-beta, c-Cbl, and PDGFR-alpha the in mammary stroma |
Q52703607 | TGF-β Family Signaling in Ductal Differentiation and Branching Morphogenesis. |
Q27012443 | Targeting TGF-β signaling in cancer |
Q37308684 | The Ron receptor tyrosine kinase negatively regulates mammary gland branching morphogenesis |
Q33904081 | The insulin-like growth factors (IGFs) and IGF binding proteins in postnatal development of murine mammary glands |
Q37863042 | The role of activin in mammary gland development and oncogenesis |
Q33772662 | The structural and mechanical complexity of cell-growth control |
Q24793229 | Transforming growth factor-beta and breast cancer: Lessons learned from genetically altered mouse models |
Q24793194 | Transforming growth factor-beta and breast cancer: Mammary gland development |
Q37340100 | Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion |
Q33643964 | Tumor-stroma interactions |
Q36516410 | Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer |
Q24801497 | Tumour-stromal interactions. Role of the stroma in mammary development |
Q24801546 | Tumour-stromal interactions. Transforming growth factor-beta isoforms and hepatocyte growth factor/scatter factor in mammary gland ductal morphogenesis |
Q35022625 | Wnt5a as an effector of TGFβ in mammary development and cancer |
Search more.